| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.313 | 43.110 | 0 | 0 | 0 | 0 | 2.557 | 43.200 | 42.887 | 37.518 |
| Total Income - EUR | 10.313 | 43.110 | 0 | 0 | 0 | 0 | 2.557 | 43.200 | 86.378 | 49.044 |
| Total Expenses - EUR | 2.833 | 32.396 | 0 | 0 | 0 | 0 | 3.604 | 22.019 | 76.725 | 47.146 |
| Gross Profit/Loss - EUR | 7.480 | 10.714 | 0 | 0 | 0 | 0 | -1.047 | 21.180 | 9.653 | 1.898 |
| Net Profit/Loss - EUR | 7.171 | 9.220 | 0 | 0 | 0 | 0 | -1.116 | 20.265 | 9.289 | 1.483 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Anniatherapy Enterprise S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.804 | 1.809 | 5.219 |
| Current Assets | 7.577 | 17.245 | 16.300 | 254 | 249 | 245 | 451 | 10.564 | 13.838 | 12.248 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 120 | 2.028 | 0 | 12.133 |
| Receivables | 0 | 15.438 | 15.177 | 0 | 0 | 0 | 0 | 5.065 | 2.931 | 0 |
| Cash | 7.577 | 1.806 | 1.123 | 254 | 249 | 245 | 331 | 3.471 | 10.907 | 115 |
| Shareholders Funds | 7.216 | 16.362 | 16.085 | 43 | 42 | 41 | -1.075 | 13.104 | 15.277 | 16.674 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 361 | 882 | 215 | 211 | 207 | 203 | 1.527 | 265 | 370 | 793 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4939 - 4939" | |||||||||
| CAEN Financial Year |
4939
|
|||||||||
Comments - Anniatherapy Enterprise S.r.l.